Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Efficient Nesting Tools Bring AM Closer to Mass Production June 6, 2019 IKEA to Shutter Its Only U.S. Manufacturing Center July 26, 2019 IoT Bridge Can Revolutionize Metal 3D Printing for Large Infrastructure November 10, 2017